Sanja Kurečić Filipović

Employment

• Croatian Institute of Public Health epidemiologist, Head of Communicable Diseases Surveillance Dept

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population
  International Journal of Epidemiology 2025 DOI: 10.1093/IJE/DYAF086
  +Save
• Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
  Eurosurveillance 2025 DOI: 10.2807/1560-7917.ES.2025.30.23.2500011
  +Save
• COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
  JAMA Network Open 2024 DOI: 10.1001/JAMANETWORKOPEN.2024.19258
  +Save
• Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024
  Vaccine 2024 DOI: 10.1016/J.VACCINE.2024.05.067
  +Save
• Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January - January 2024 (vol 42, pg 3931, 2024)
  Vaccine 2024 DOI: 10.1016/J.VACCINE.2024.06.056
  +Save
• Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024
  Influenza and Other Respiratory Viruses 2024 DOI: 10.1111/IRV.70009
  +Save
• Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe
  Vaccine 2024 DOI: 10.1016/J.VACCINE.2024.04.060
  +Save
• Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study
  Influenza and Other Respiratory Viruses 2023 DOI: 10.1111/IRV.13069
  +Save
• Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
  Eurosurveillance 2022 DOI: 10.2807/1560-7917.ES.2022.27.21.2101104
  +Save
• Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine
  Influenza and Other Respiratory Viruses 2020 DOI: 10.1111/IRV.12714
  +Save